Centre Hospitalier Regional Universitaire de Lille

Lille, Hauts-de-France 59037

0 studies enrolling now · 2 studies all time

What they study most

Multiple Myeloma, Myeloid Leukemia, Chronic, Chronic Phase

Studies at this site

• Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses — Completed
• A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma — Stopped early